Wedbush Starts Endocyte (ECYT) at Outperform, EC145 Brings $7-$10 In Value Per Share
Tweet Send to a Friend
Wedbush initiates coverage on shares of Endocyte (NASDAQ: ECYT) with an Outperform rating and $20 price target.
The firm ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
The firm ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
